184 related articles for article (PubMed ID: 15601620)
1. Apelin signalling: a promising pathway from cloning to pharmacology.
Masri B; Knibiehler B; Audigier Y
Cell Signal; 2005 Apr; 17(4):415-26. PubMed ID: 15601620
[TBL] [Abstract][Full Text] [Related]
2. Structural and functional study of the apelin-13 peptide, an endogenous ligand of the HIV-1 coreceptor, APJ.
Fan X; Zhou N; Zhang X; Mukhtar M; Lu Z; Fang J; DuBois GC; Pomerantz RJ
Biochemistry; 2003 Sep; 42(34):10163-8. PubMed ID: 12939143
[TBL] [Abstract][Full Text] [Related]
3. The apelin receptor APJ: journey from an orphan to a multifaceted regulator of homeostasis.
O'Carroll AM; Lolait SJ; Harris LE; Pope GR
J Endocrinol; 2013 Oct; 219(1):R13-35. PubMed ID: 23943882
[TBL] [Abstract][Full Text] [Related]
4. International Union of Basic and Clinical Pharmacology. LXXIV. Apelin receptor nomenclature, distribution, pharmacology, and function.
Pitkin SL; Maguire JJ; Bonner TI; Davenport AP
Pharmacol Rev; 2010 Sep; 62(3):331-42. PubMed ID: 20605969
[TBL] [Abstract][Full Text] [Related]
5. Emerging roles of apelin in biology and medicine.
Kleinz MJ; Davenport AP
Pharmacol Ther; 2005 Aug; 107(2):198-211. PubMed ID: 15907343
[TBL] [Abstract][Full Text] [Related]
6. Endocrine receptors as targets for new drugs.
Altman J
Neuroendocrinology; 2006; 83(5-6):282-8. PubMed ID: 16926529
[TBL] [Abstract][Full Text] [Related]
7. Cloning and activation of the bullfrog apelin receptor: Gi/o coupling and high affinity for [Pro1]apelin-13.
Moon MJ; Oh DY; Moon JS; Kim DK; Hwang JI; Lee JY; Kim JI; Cho S; Kwon HB; Seong JY
Mol Cell Endocrinol; 2007 Oct; 277(1-2):51-60. PubMed ID: 17825479
[TBL] [Abstract][Full Text] [Related]
8. Central and peripheral cardiovascular actions of apelin in conscious rats.
Kagiyama S; Fukuhara M; Matsumura K; Lin Y; Fujii K; Iida M
Regul Pept; 2005 Feb; 125(1-3):55-9. PubMed ID: 15582714
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic potential of interfering with apelin signalling.
Sorli SC; van den Berghe L; Masri B; Knibiehler B; Audigier Y
Drug Discov Today; 2006 Dec; 11(23-24):1100-6. PubMed ID: 17129829
[TBL] [Abstract][Full Text] [Related]
10. Effects of olmesartan on Apelin/APJ and Akt/endothelial nitric oxide synthase pathway in Dahl rats with end-stage heart failure.
Fukushima H; Kobayashi N; Takeshima H; Koguchi W; Ishimitsu T
J Cardiovasc Pharmacol; 2010 Jan; 55(1):83-8. PubMed ID: 19904215
[TBL] [Abstract][Full Text] [Related]
11. Apelin: a novel neurohumoral modulator of the cardiovascular system. Pathophysiologic importance and potential use as a therapeutic target.
Falcão-Pires I; Leite-Moreira AF
Rev Port Cardiol; 2005 Oct; 24(10):1263-76. PubMed ID: 16398242
[TBL] [Abstract][Full Text] [Related]
12. The N-terminal domain of APJ, a CNS-based coreceptor for HIV-1, is essential for its receptor function and coreceptor activity.
Zhou N; Zhang X; Fan X; Argyris E; Fang J; Acheampong E; DuBois GC; Pomerantz RJ
Virology; 2003 Dec; 317(1):84-94. PubMed ID: 14675627
[TBL] [Abstract][Full Text] [Related]
13. The apelin-APJ system in heart failure: pathophysiologic relevance and therapeutic potential.
Japp AG; Newby DE
Biochem Pharmacol; 2008 May; 75(10):1882-92. PubMed ID: 18272138
[TBL] [Abstract][Full Text] [Related]
14. Apelin suppresses apoptosis of human vascular smooth muscle cells via APJ/PI3-K/Akt signaling pathways.
Cui RR; Mao DA; Yi L; Wang C; Zhang XX; Xie H; Wu XP; Liao XB; Zhou H; Meng JC; Yuan LQ; Liao EY
Amino Acids; 2010 Nov; 39(5):1193-200. PubMed ID: 20495838
[TBL] [Abstract][Full Text] [Related]
15. Unravelling the roles of the apelin system: prospective therapeutic applications in heart failure and obesity.
Lee DK; George SR; O'Dowd BF
Trends Pharmacol Sci; 2006 Apr; 27(4):190-4. PubMed ID: 16530855
[TBL] [Abstract][Full Text] [Related]
16. Apelin suppresses apoptosis of human osteoblasts.
Xie H; Yuan LQ; Luo XH; Huang J; Cui RR; Guo LJ; Zhou HD; Wu XP; Liao EY
Apoptosis; 2007 Jan; 12(1):247-54. PubMed ID: 17136493
[TBL] [Abstract][Full Text] [Related]
17. G protein-coupled APJ receptor signaling induces focal adhesion formation and cell motility.
Hashimoto Y; Ishida J; Yamamoto R; Fujiwara K; Asada S; Kasuya Y; Mochizuki N; Fukamizu A
Int J Mol Med; 2005 Nov; 16(5):787-92. PubMed ID: 16211245
[TBL] [Abstract][Full Text] [Related]
18. Regulation of G protein-coupled receptor signalling: focus on the cardiovascular system and regulator of G protein signalling proteins.
Hendriks-Balk MC; Peters SL; Michel MC; Alewijnse AE
Eur J Pharmacol; 2008 May; 585(2-3):278-91. PubMed ID: 18410914
[TBL] [Abstract][Full Text] [Related]
19. Immunocytochemical localisation of the apelin receptor, APJ, to human cardiomyocytes, vascular smooth muscle and endothelial cells.
Kleinz MJ; Skepper JN; Davenport AP
Regul Pept; 2005 Mar; 126(3):233-40. PubMed ID: 15664671
[TBL] [Abstract][Full Text] [Related]
20. Elucidation of the structure-activity relationships of apelin: influence of unnatural amino acids on binding, signaling, and plasma stability.
Murza A; Parent A; Besserer-Offroy E; Tremblay H; Karadereye F; Beaudet N; Leduc R; Sarret P; Marsault É
ChemMedChem; 2012 Feb; 7(2):318-25. PubMed ID: 22170700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
